FDA Inspection 1204459 — South Florida Institute For Reproductive Medicine

South Florida Institute For Reproductive Medicine — FEI 3007787718

The FDA completed an inspection of South Florida Institute For Reproductive Medicine on Apr 19, 2023 in Naples, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Apr 19, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Naples, FL (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.